Given that NSCLC H1299 cells carry a defective Grx-GSH system34, our study focuses on the impact of Trx1 and TrxR1 inhibition in NSCLC cells with a defective Grx-GSH system. This evidence concerns the gene TXN and non-small cell lung carcinoma.